Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy Sequencing [0.03%]
转移性乳腺癌临床试验的解读：优化治疗顺序的实际见解
Chiara Corti,Hope S Rugo,Sara M Tolaney
Chiara Corti
The art of sequencing therapy in the management of breast cancer is a multifaceted challenge that demands the careful integration of clinical trial data, real-world evidence, and individualized patient factors to guide treatment decisions. ...
The Art of Oncology Education and Knowledge Sharing-It is All About the "How" [0.03%]
肿瘤学教育和知识共享的艺术——重点在于“如何”教学
Guilherme Sacchi de Camargo Correia,Lori J Rosenstein,Rohit Gosain et al.
Guilherme Sacchi de Camargo Correia et al.
In the rapidly evolving field of oncology, education and knowledge sharing have become essential aspects of oncology practice and must-needed tools to help patients conquer cancer. Oncology education is an art that needs to be mastered by a...
Elias Jabbour,Fadi G Haddad,Hagop Kantarjian
Elias Jabbour
Older patients with ALL often have high-risk disease characterized by adverse-risk cytogenetic and molecular abnormalities, as well as Philadelphia chromosome (Ph)-positive and Ph-like phenotypes. They often have comorbidities resulting in ...
Erin Crane,Stéphanie Gaillard,Martee Leigh Hensley
Erin Crane
Rare uterine malignancies present treatment challenges because of their clinical and biological heterogeneity. Among the rarest of the uterine cancers are leiomyosarcomas, uterine stromal tumors, and the mesonephric-like and serous carcinom...
Gita Suneja,Marjorie C Green,Janaki Parameswaran et al.
Gita Suneja et al.
Early-career oncologists navigate a complex landscape of professional development, clinical responsibilities, and research endeavors. This manuscript explores key challenges and strategies for success in the early years of an oncology caree...
Aditya Bagrodia,Hege Sagstuen Haugnes,Ragnhild Hellesnes et al.
Aditya Bagrodia et al.
Testicular cancer is a rare but highly curable malignancy, predominantly affecting young men. Advances in multimodal therapy, including cisplatin-based chemotherapy, radiotherapy, and surgical interventions, have resulted in excellent cance...
Financial Toxicity and Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene? [0.03%]
乳腺癌的经济毒性：为什么重要，谁有风险以及如何干预？
Kamaria L Lee,Alexandru Eniu,Christopher M Booth et al.
Kamaria L Lee et al.
Financial toxicity, or the financial burden patients experience because of medical costs, can lead to negative patient effects including lower quality of life, compromised clinical care, and worse health outcomes. People with cancer and sur...
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence-Enabled Multidisciplinary Oncology [0.03%]
从知识到行动：利用人工智能赋能的多学科肿瘤学构建更好的未来
Arturo Loaiza-Bonilla,Nikhil Thaker,Caroline Chung et al.
Arturo Loaiza-Bonilla et al.
Artificial intelligence (AI) is transforming multidisciplinary oncology at an unprecedented pace, redefining how clinicians detect, classify, and treat cancer. From earlier and more accurate diagnoses to personalized treatment planning, AI'...
Perioperative Therapy in Oncogene-Driven Non-Small Cell Lung Cancer: Current Strategies and Unanswered Questions [0.03%]
驱动基因阳性非小细胞肺癌的围手术期治疗：现有策略及未解之谜
Teja Voruganti,Rosalyn Marar,Benjamin Bleiberg et al.
Teja Voruganti et al.
Perioperative therapy has become a critical component in the management of resectable non-small cell lung cancer (NSCLC), particularly in the era of precision medicine. Although molecular testing is standard in metastatic NSCLC, its incorpo...
Pegylated Interferons: Still a Major Player for the Treatment of Myeloproliferative Neoplasms [0.03%]
聚乙二醇干扰素：仍然是治疗骨髓增殖性肿瘤的重要药物
Michael Daunov,Rebecca B Klisovic
Michael Daunov
Over the past 35 years, interferons have been explored in various formulations for the management of Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), such as essential thrombocythemia (ET), polycythemia vera (PV), and m...